HTLV-1 can be involved in acceleration of different nonhematological cancers
Journal Title: Journal of Cancer Research & Therapy - Year 2019, Vol 7, Issue 1
Abstract
In the past two decades it has been found that viral proteins might contribute to activation of numerous pathways involved in different types of cancer. Human T-lymphotropic virus 1 (HTLV-1), well known as a cause of T-cell leukemia, was found in patients having different types of cancers. Initiation and development of cancers is usually a multi-year multistep process that starts with initiation of the first somatic mutation and the then the next set of steps with the occurrence of an increasing number of somatic mutations with specific times for each one. Here we suggest a hypothesis: If HTLV-1 virus can infect the nonhematological cell, its viral proteins can work as the agents activating the general cancer-related pathways. This way Tax HTLV-1 protein (and/or other viral proteins) can serve in the similar way as the somatic mutation of specified genes and the presence of Tax can affect the functionality of several pathways that are not yet activated by the timeline of the stages of a “normal” cancer development. For example, the pathways PI3K, p53, TGF-β can be correspondingly be activated and inhibited by Tax before their functional change would appear by the timeline of a “normal” cancer development. The HTLV-1 infection-related KEGG pathway was found when the sets of the most frequently mutated genes for several cancers were analyzed by the DAVID program program (that selects the most probable pathways for a set of selected genes). These findings support the hypotheses that HTLV-1 infection can be a common factor in the development of very different cancers, thus warranting further exploration.
Authors and Affiliations
Valentina L Kouznetsova, Steven Chen, Igor F Tsigelny
Keywords
Related Articles
- EP ID EP534963
- DOI 10.14312/2052-4994.2019-1
- Views 79
- Downloads 0
Calcification of peritoneum and peritoneal fluid perfusion malfunction in carcinomatosis of serous membranes of peritoneal cavity
The article describes the peritoneal calcification in peritoneal carcinomatosis, as well as its possible role in the development of carcinomatosis within the frames of the authors’ alternative theory. The analysis of the...
Synergistic antineoplastic action of 5-aza-2'deoxycytidine (decitabine) in combination with different inhibitors of enhancer of zeste homolog 2 (EZH2) on human lung carcinoma cells
Patients with metastatic lung cancer have a very poor prognosis indicating an urgent need to develop more effective chemotherapy. Aberrant promoter DNA methylation can result in the epigenetic silencing of tumor suppress...
Development of a new formulation of interferons (HEBERPAG) for BCC treatment
Purpose: This work is aimed to show briefly, the clinical development of a new pharmaceutical formulation of interferons for the treatment of basal cell carcinoma. Methods: A rationale design of the combination of IFN-α2...
Cancer estimation of incidence and survival in Algeria 2014
Cancer is one of the major public health problems in Algeria. In the last 25 years, a significant increase in the incidence of the major types of cancers has been observed in both sexes. Moreover, the 5-year survival rat...
Total meso-esophagogastrectomy in surgically resectable Siewert type II-III junctional gastric cancer: Safety and long term oncologic outcome
Aim: To analyze our experience confronting meso-esophagogastric resection (transhiatally extended total gastrectomy en-bloc with its inviolate primitive dorsal and ventral mesenterium) to less radical planes of surgery (...